Stocks · Health care · Pharmaceutical Preparations

ARROWHEAD PHARMACEUTICALS, INC.

ARWR Clue Score51
United States Fiscal year ends September CIK 0000879407 Results filed 4 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Christopher Richard Anzalone
29 Dec 2025
Chief Executive Officer
Sold after exercise
16,545
$68.69
$1.14M
Christopher Richard Anzalone
29 Dec 2025
Chief Executive Officer
Sold after exercise
35,181
$69.33
$2.44M

What was left out

Form 4 filings counted 30
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 42
Sales straight out of an exercise 2
Sales at will 20
Transactions with no price 0
Shares from compensation/vesting 528,641
History held since 15 Nov 2006